WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹167 Cr | ₹136 Cr | ₹117 Cr | ₹111 Cr | ₹79 Cr |
What is the latest Sundry Debtors ratio of WINDLAS BIOTECH ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹167 Cr |
| Mar2024 | ₹136 Cr |
| Mar2023 | ₹117 Cr |
| Mar2022 | ₹111 Cr |
| Mar2021 | ₹79 Cr |
How is Sundry Debtors of WINDLAS BIOTECH Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹167 Cr | 22.44 | |
| Mar2024 | ₹136 Cr | 16.62 | |
| Mar2023 | ₹117 Cr | 5.50 | |
| Mar2022 | ₹111 Cr | 39.49 | |
| Mar2021 | ₹79 Cr | - | |
Compare Sundry Debtors of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,644.0 Cr | 4.5% | -9% | -21.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,195.0 Cr | 0.9% | 12.7% | 8.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,993.0 Cr | -0.4% | 9.7% | 11.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,926.0 Cr | 0.5% | 5.8% | 36.5% | Stock Analytics | |
| CIPLA | ₹113,052.0 Cr | -2.7% | 13.9% | -6.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,333.0 Cr | 1.5% | 7.3% | 8% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | 4.5% |
-9% |
-21.6% |
| SENSEX | 1% |
-4.1% |
-7.4% |
You may also like the below Video Courses